Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c)  Almanza-Aguilera, E. et al., 2024
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/219646

Prediagnostic plasma nutrimetabolomics and prostate cancer risk: a nested case–control analysis within the EPIC study 

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Background and Objective: Nutrimetabolomics may reveal novel insights into early metabolic alterations and the role of dietary exposures on prostate cancer (PCa) risk. We aimed to prospectively investigate the associations between plasma metabolite concentrations and PCa risk, including clinically relevant tumor subtypes. Methods: We used a targeted and large-scale metabolomics approach to analyze plasma samples of 851 matched PCa case-control pairs from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Associations between metabolite concentrations and PCa risk were estimated by multivariate conditional logistic regression analysis. False discovery rate (FDR) was used to control for multiple testing correction. Results: Thirty-one metabolites (predominately derivatives of food intake and microbial metabolism) were associated with overall PCa risk and its clinical subtypes (p < 0.05), but none of the associations exceeded the FDR threshold. The strongest positive and negative associations were for dimethylglycine (OR = 2.13; 95% CI 1.16-3.91) with advanced PCa risk (n = 157) and indole-3-lactic acid (OR = 0.28; 95% CI 0.09-0.87) with fatal PCa risk (n = 57), respectively; however, these associations did not survive correction for multiple testing. Conclusions: The results from the current nutrimetabolomics study suggest that apart from early metabolic deregulations, some biomarkers of food intake might be related to PCa risk, especially advanced and fatal PCa. Further independent and larger studies are needed to validate our results.

Matèries (anglès)

Citació

Citació

ALMANZA AGUILERA, Enrique, MARTÍNEZ HUÉLAMO, Miriam, LÓPEZ-HERNÁNDEZ, Yamilé, GUIÑÓN FORT, Daniel, GUADALL, Anna, CRUZ, Meryl, PEREZ-CORNAGO, Aurora, ROSTGAARD-HANSEN, Agnetha linn, TJØNNELAND, Anne, DAHM, Christina c., KATZKE, Verena, SCHULZE, Matthias b., MASALA, Giovanna, AGNOLI, Claudia, TUMINO, Rosario, RICCERI, Fulvio, LASHERAS, Cristina, CROUS BOU, Marta, SÁNCHEZ, Maria-josé, AIZPURUA-ATXEGA, Amaia, GUEVARA, Marcela, TSILIDIS, Konstantinos k., CHRYSOVALANTOU CHATZIIOANNOU, Anastasia, WEIDERPASS, Elisabete, TRAVIS, Ruth c., WISHART, David s., ANDRÉS LACUEVA, Ma. cristina, ZAMORA-ROS, Raul. Prediagnostic plasma nutrimetabolomics and prostate cancer risk: a nested case–control analysis within the EPIC study . _Cancers_. 2024. Vol. 16, núm. 23. [consulta: 28 de gener de 2026]. ISSN: 2072-6694. [Disponible a: https://hdl.handle.net/2445/219646]

Exportar metadades

JSON - METS

Compartir registre